Integrative Modeling of Multiomics Data for Predicting Tumor Mutation Burden in Patients with Lung Cancer

Figure 2

Division of patients with LUAD into TMB-H and TMB-L subgroups. (a) The distribution of TMB in patients with LUAD; (b) the number of TMB-H and TMB-L patients with LUAD; (c) the distribution of TMB across different tumor stages. TMB: tumor mutation burden; LUAD: lung adenocarcinoma; TMB-H: TMB-high; TMB-L: TMB-low; OS: overall survival.

(a)

(b)

(c)